Dihydroquinazoline-carboxamide-34
General
Type : Carboxamide,Multitarget,5-Lipoxygenase inhibitor,Sulfur Compound,Quinazoline
Chemical_Nomenclature : 2-((2-Chlorobenzyl)thio)-N-neopentyl-4-oxo-3,4-dihydroquinazoline-7-carboxamide
Canonical SMILES : N(C(=O)C1=CC=C2C(=C1)N=C(NC2=O)SCC3=CC=CC=C3Cl)CC(C)(C)C
InChI : InChI=1S\/C21H22ClN3O2S\/c1-21(2,3)12-23-18(26)13-8-9-15-17(10-13)24-20(25-19(15)27)28-11-14-6-4-5-7-16(14)22\/h4-10H,11-12H2,1-3H3,(H,23,26)(H,24,25,27)
InChIKey : ZKEJKUPAMSFZOI-UHFFFAOYSA-N
Other name(s) :
MW : 415.93
Formula : C21H22ClN3O2S
CAS_number :
PubChem :
UniChem : ZKEJKUPAMSFZOI-UHFFFAOYSA-N
IUPHAR :
Wikipedia :
Target
Families : Dihydroquinazoline-carboxamide-34 ligand of proteins in family: Epoxide_hydrolase
Stucture :
Protein : human-EPHX2
References (1)
| Title : Quinazoline-4(3H)-one-7-carboxamide Derivatives as Human Soluble Epoxide Hydrolase Inhibitors with Developable 5-Lipoxygenase Activating Protein Inhibition - Turanli_2022_ACS.Omega_7_36354 |
| Author(s) : Turanli S , Ergul AG , Jordan PM , Olgac A , Caliskan B , Werz O , Banoglu E |
| Ref : ACS Omega , 7 :36354 , 2022 |
| Abstract : Turanli_2022_ACS.Omega_7_36354 |
| ESTHER : Turanli_2022_ACS.Omega_7_36354 |
| PubMedSearch : Turanli_2022_ACS.Omega_7_36354 |
| PubMedID: 36278102 |